Market Overview

JP Morgan Maintains Overweight on Aegerion Pharmaceuticals, Inc., Raises PT to $30.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS

Latest Ratings for AEGR

DateFirmActionFromTo
Dec 2015Guggenheim SecuritiesUpgradesSellBuy
Nov 2015Bank of AmericaUpgradesUnderperformNeutral
Nov 2015Leerink SwannMaintainsOutperform

View More Analyst Ratings for AEGR
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (AEGR)

Get Benzinga's Newsletters